| 1 | ADAM8
|
| The Effect of ADAM8 on the Proliferation and Apoptosis of Hepatocytes and Hepatoma Carcinoma Cells.
|
| Li SQ, Hu ZH, Zhu S, Wang DM, Han HM, Lu HJ.
|
| J Biochem Mol Toxicol Biochem Mol Toxicol. 2015 Aug 21. doi: 10.1002/jbt.21737. [Epub ahead of print]
2015
|
| 2 | ADAM8
|
| ADAM8 as a drug target in pancreatic cancer.
|
| Schlomann U, Koller G, Conrad C, Ferdous T, Golfi P, Garcia AM, Höfling S, Parsons M, Costa P, Soper R, Bossard M, Hagemann T, Roshani R, Sewald N, Ketchem RR, Moss ML, Rasmussen FH, Miller MA, Lauffenburger DA, Tuveson DA, Nimsky C, Bartsch JW.
|
| Nat Commun 6:6175. doi: 10.1038/ncomms7175.
2015
|
| 3 | ADAM8
|
| Roles of ADAM8 in elimination of injured muscle fibers prior to skeletal muscle regeneration.
|
| Nishimura D, Sakai H, Sato T, Sato F, Nishimura S, Toyama-Sorimachi N, Bartsch JW, Sehara-Fujisawa A.
|
| Mech Dev 135:58-67. doi: 10.1016/j.mod.2014.12.001. Epub 2014 Dec 12.
2015
|
| 4 | ADAM8
|
| N-glycosylation regulates ADAM8 processing and activation.
|
| Srinivasan S, Romagnoli M, Bohm A, Sonenshein GE.
|
| J Biol Chem 289(48):33676-88. doi: 10.1074/jbc.M114.594242. Epub 2014 Oct 21.
2014
|
| 5 | ADAM8
|
| ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.
|
| Romagnoli M, Mineva ND, Polmear M, Conrad C, Srinivasan S, Loussouarn D, Barillé-Nion S, Georgakoudi I, Dagg Á, McDermott EW, Duffy MJ, McGowan PM, Schlomann U, Parsons M, Bartsch JW, Sonenshein GE.
|
| EMBO Mol Med 6(2):278-94. doi: 10.1002/emmm.201303373. Epub 2013 Dec 27.
2014
|
| 6 | ADAM8
|
| High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
|
| Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M.
|
| Pathol Oncol Res 19(1):79-88. doi: 10.1007/s12253-012-9560-6. Epub 2012 Sep 12.
2013
|
| 7 | ADAM8, PRNP
|
| Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.
|
| Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA, Kong Q.
|
| J Biol Chem 287(20):16510-20. doi: 10.1074/jbc.M112.360891. Epub 2012 Mar 23.
2012
|
| 8 | ADAM8, SELPLG
|
| The metalloprotease ADAM8 is associated with and regulates the function of the adhesion receptor PSGL-1 through ERM proteins.
|
| Domínguez-Luis M, Lamana A, Vazquez J, García-Navas R, Mollinedo F, Sánchez-Madrid F, Díaz-González F, Urzainqui A.
|
| Eur J Immunol 41(12):3436-42.
2011
|
| 9 | ADAM8
|
| ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo.
|
| Ishizuka H, García-Palacios V, Lu G, Subler MA, Zhang H, Boykin CS, Choi SJ, Zhao L, Patrene K, Galson DL, Blair HC, Hadi TM, Windle JJ, Kurihara N, Roodman GD.
|
| J Bone Miner Res 26(1):169-81. doi: 10.1002/jbmr.199.
2011
|
| 10 | ADAM8
|
| Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer.
|
| Hernández I, Moreno JL, Zandueta C, Montuenga L, Lecanda F.
|
| Oncogene 29(26):3758-69. doi: 10.1038/onc.2010.130. Epub 2010 May 10.
2010
|
| 11 | ADAM8
|
| ADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice.
|
| Mahoney ET, Benton RL, Maddie MA, Whittemore SR, Hagg T.
|
| J Comp Neurol 512(2):243-55. doi: 10.1002/cne.21902.
2009
|
| 12 | ADAM8
|
| Hypoxia-dependent expression of ADAM8 in human pancreatic cancer cell lines.
|
| Valkovskaya NV.
|
| Exp Oncol 30(2):129-32. Erratum in: Exp Oncol. 2008 Sep;30(3):255.
2008
|
| 13 | ADAM8
|
| Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding.
|
| Gómez-Gaviro M, Domínguez-Luis M, Canchado J, Calafat J, Janssen H, Lara-Pezzi E, Fourie A, Tugores A, Valenzuela-Fernández A, Mollinedo F, Sánchez-Madrid F, Díaz-González F.
|
| J Immunol 178(12):8053-63.
2007
|
| 14 | ADAM8
|
| ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer.
|
| Valkovskaya N, Kayed H, Felix K, Hartmann D, Giese NA, Osinsky SP, Friess H, Kleeff J.
|
| J Cell Mol Med 11(5):1162-74.
2007
|
| 15 | ADAM19, ADAM8
|
| Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
|
| Wildeboer D, Naus S, Amy Sang QX, Bartsch JW, Pagenstecher A.
|
| J Neuropathol Exp Neurol 65(5):516-27.
2006
|
| 16 | ADAM8
|
| Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
|
| Naus S, ReipschlŠger S, Wildeboer D, Lichtenthaler SF, Mitterreiter S, Guan Z, Moss ML, Bartsch JW.
|
| Biol Chem 387(3):337-46. 2006
|
| 17 | ADAM8, ADAM15, ADAM28
|
| Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23.
|
| Fourie AM, Coles F, Moreno V, Karlsson L.
|
| J Biol Chem 278(33):30469-77. Epub 2003 May 30. 2003
|
| 18 | ADAM8
|
| ADAM8: a novel osteoclast stimulating factor.
|
| Choi SJ, Han JH, Roodman GD.
|
| J Bone Miner Res 16(5):814-22. 2001
|
| 19 | ADAM8
|
| CD156 (human ADAM8) : expression, primary amino acid sequence, and gene location.
|
| Yoshiyama K, et al.
|
| Genomics 41 : 56-62. 1997
|
| 20 | ADAM8, ADAM10, ADAM11
|
| ADAM, a novel family of membrane proteins containing A disintegrin and metalloprotease domain : multipotential functions in cell-cell and cell-matrix interactions.
|
| Wolfsberg TG, et al.
|
| J Cell Biol 131 : 275-278. 1995
|